AI brief of an SEC Form 8-K · Innovative Eyewear Inc (LUCY)

Innovative Eyewear gets $3.0 million from warrant exercise at reduced $1.35 price

Mixed Impact 3 of 5 financing Written later

Innovative Eyewear, Inc. (Nasdaq: LUCY) agreed on July 8, 2026 to induce holders to exercise 2,200,544 existing warrants for cash at a reduced price of $1.35 per share, down from $2.60. In exchange, the company will issue new unregistered Series J warrants for up to 6,601,632 shares, and gross proceeds of about $3.0 million are expected before placement agent fees and expenses, with closing on July 9, 2026. The deal brings in cash but adds potential dilution for shareholders through the new warrants and placement agent warrants.

Key points

  • 2,200,544 existing warrants exercised for cash at a reduced $1.35 per share, versus an original $2.60 exercise price
  • New Series J warrants cover up to 6,601,632 shares at a $1.10 exercise price, sold at $0.125 per warrant
  • Gross proceeds of approximately $3.0 million before fees; the company cites working capital and general corporate purposes as the intended use
  • H.C. Wainwright & Co. is placement agent, with a 7.5% cash fee plus a 1.0% management fee and warrants for up to 165,041 shares at $1.6875; the offering closed July 9, 2026

The filing

CompanyInnovative Eyewear Inc (LUCY)
Form8-K, current report
Filed with the SECJul 9, 2026, 4:30 PM ET
Accession number0001829126-26-007468

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 09, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.